New agent inhibits HCV replication in mouse models -- No resistance seen

(American Society for Microbiology) Treatments against hepatitis C virus have only been partially successful. A major problem is that antivirals generate drug resistance. Now Seong-Wook Lee of Dankook University, Yongin, Republic of Korea and his collaborators have developed agents that bind to the business end of a critical protein, disabling it so successfully that no resistance has arisen. The research is published in the June 2013 issue of the Journal of Virology.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news